Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders' Equity

v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Follow-on Offering
Follow-on Offering
Common Stock
Follow-on Offering
Additional Paid-In Capital
At-The-Market Financing
At-The-Market Financing
Common Stock
At-The-Market Financing
Additional Paid-In Capital
Private Placement Offering
Private Placement Offering
Common Stock
Private Placement Offering
Additional Paid-In Capital
Babyshelf Offering
Babyshelf Offering
Common Stock
Babyshelf Offering
Additional Paid-In Capital
Balance at Dec. 31, 2022 $ 8,507,793 $ 1,096 $ 52,729,942 $ (44,207,272) $ (15,973)                        
Balance, Shares at Dec. 31, 2022   10,955,904                              
Issuance of common shares upon exercise of stock options 1,433 $ 1 1,432                            
Issuance of common shares upon exercise of stock options, Shares   750                              
Issuance of restricted stock 731,661 $ 28 731,633                            
Issuance of restricted stock, Shares   291,469                              
Stock-based compensation expense 3,089,304   3,089,304                            
Issuance of stock options to satisfy accrued bonus 974,224   974,224                            
Issuance of common shares           $ 4,156,859 $ 256 $ 4,156,603 $ 1,154,437 $ 76 $ 1,154,361       $ 1,393,883 $ 242 $ 1,393,641
Issuance of common shares, Shares             2,555,500     758,388           2,424,243  
Issuance of warrants to underwriter in connection with initial public offering 241,109   241,109                            
Foreign currency translation adjustment (287)       (287)                        
Net loss (19,772,905)     (19,772,905)                          
Balance at Dec. 31, 2023 477,511 $ 1,699 64,472,249 (63,980,177) (16,260)                        
Balance, Shares at Dec. 31, 2023   16,986,254                              
Issuance of common shares upon exercise of stock options $ 217,158 $ 12 217,146                            
Issuance of common shares upon exercise of stock options, Shares 120,110 120,110                              
Issuance of restricted stock $ 179,490 $ 7 179,483                            
Issuance of restricted stock, Shares   75,550                              
Stock-based compensation expense 1,912,744   1,912,744                            
Issuance of common shares                 $ 9,453,195 $ 328 $ 9,452,867 $ 2,684,503 $ 516 $ 2,683,987      
Issuance of common shares, Shares           22,869       3,274,360     5,156,205        
Issuance of warrants in connection                       $ 1,917,075   $ 1,917,075      
Exercise of warrants, shares   545,309                              
Exercise of warrants 3,191,675 $ 54 3,191,621                            
Reclassification of liability classified warrants to equity 6,870,296   6,870,296                            
Foreign currency translation adjustment (14,355)       (14,355)                        
Net loss (23,254,656)     (23,254,656)                          
Balance at Dec. 31, 2024 $ 3,634,636 $ 2,616 $ 90,897,468 $ (87,234,833) $ (30,615)                        
Balance, Shares at Dec. 31, 2024   26,157,788